Literature DB >> 21652610

Epidemiology of multiple sclerosis in south-western Sardinia.

Eleonora Cocco1, Claudia Sardu, Rita Massa, Elena Mamusa, Luigina Musu, Paola Ferrigno, Maurizio Melis, Cristina Montomoli, Virginia Ferretti, Giancarlo Coghe, Giuseppe Fenu, Jessica Frau, Lorena Lorefice, Nicola Carboni, Paolo Contu, Maria G Marrosu.   

Abstract

BACKGROUND: Sardinia is a known high-risk area for multiple sclerosis (MS), but no data for south-western Sardinia (SWS) are available. SWS has a genetically homogeneous population, apart from St Peter Island, and represents a peculiar environment related to the industrial, mineralogical and military economy.
OBJECTIVE: To estimate prevalence and incidence and to evaluate temporal trends and geographical distribution of MS in SWS.
METHODS: MS prevalence was evaluated on 31 December 2007 and crude mean annual incidence rate was defined between 2003 and 2007. Temporal trend in MS incidence was assessed using the Armitage test. To identify MS clusters, Standard Morbidity Ratio (SMR) was calculated for each village and geographical distribution prevalence by means of a Bayesian hierarchical model.
RESULTS: Total crude prevalence rate was 210.4 (95% CI 186.3-234.5): 280.3 (95% CI 241.4-319.3) for females, 138 (95% CI 110.1-165.8) for males. The crude mean annual incidence rate was 9.7/100,000 (95% CI 3.4-13.2): 4.7/100,000 (95% CI 2.4-17.0) and 14.6/100,000 (95% CI 11.8-34.8) for males and females respectively. MS incidence has increased over the last 50 years. Cluster analysis showed an SMR of 0.2 (95% CI 0.05-0.68, p = 0.002) on the island of San Pietro, and 2.0 (95% CI 1.35-2.95, p = 0.001) in Domusnovas. Spatial distribution of MS was confirmed by Bayesian geographical analysis.
CONCLUSIONS: Our data confirm Sardinia as a high-risk area for MS and support the relevance of genetic factors in MS, as evidenced in St Peter Island. However, we found an unexpectedly high MS prevalence in one village, in particular in males, suggesting an environmental influence on MS occurrence.

Entities:  

Mesh:

Year:  2011        PMID: 21652610     DOI: 10.1177/1352458511408754

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  25 in total

Review 1.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

2.  Attitude towards physical activity in patients with multiple sclerosis: a cohort study.

Authors:  Jessica Frau; G Coghe; L Lorefice; G Fenu; B Cadeddu; M G Marrosu; E Cocco
Journal:  Neurol Sci       Date:  2015-02-04       Impact factor: 3.307

3.  Neuroimmunology: B cells and variant BAFF in autoimmune disease.

Authors:  Manuel Comabella
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

4.  Estimated prevalence of multiple sclerosis in Italy in 2015.

Authors:  Mario Alberto Battaglia; Daiana Bezzini
Journal:  Neurol Sci       Date:  2016-12-31       Impact factor: 3.307

5.  Changes in first-line injectable disease-modifying therapy for multiple sclerosis: predictors of non-adherence, switching, discontinuation, and interruption of drugs.

Authors:  Luca Degli Esposti; Carlo Piccinni; Diego Sangiorgi; Valentina Perrone; Lucia Aledda; Maria Giovanna Marrosu; Fabio Lombardo
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

6.  The incidence and prevalence of neuromyelitis optica: a systematic review.

Authors:  Ruth Ann Marrie; Caroline Gryba
Journal:  Int J MS Care       Date:  2013

7.  Multiple sclerosis incidence in Tuscany from administrative data.

Authors:  Daiana Bezzini; L Policardo; F Profili; G Meucci; M Ulivelli; S Bartalini; P Francesconi; M A Battaglia
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

8.  Progressive multiple sclerosis and mood disorders.

Authors:  Lorena Lorefice; G Fenu; G Trincas; M F Moro; J Frau; G C Coghe; E Cocco; M G Marrosu; M G Carta
Journal:  Neurol Sci       Date:  2015-04-22       Impact factor: 3.307

9.  Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.

Authors:  Lorena Lorefice; Giuseppe Fenu; Roberta Pitzalis; Giulia Scalas; Jessica Frau; Giancarlo Coghe; Luigina Musu; Vincenzo Sechi; Maria Antonietta Barracciu; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2018-03-05       Impact factor: 4.849

10.  Multiple sclerosis spatial cluster in Tuscany.

Authors:  Daiana Bezzini; Pasquale Pepe; Francesco Profili; Giuseppe Meucci; Monica Ulivelli; Sabina Bartalini; Mario A Battaglia; Paolo Francesconi
Journal:  Neurol Sci       Date:  2017-10-10       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.